— from Streamed.News —
Understanding why a voice agent fails requires diagnostic metrics, particularly the accuracy of transcribing key entities. Issues like incorrect confirmation codes or flight details prevent task progression, even if the agent initially transcribes them correctly, because subsequent Large Language Mo
Experts anticipate that future combination therapies for ATTR-CM, including emerging monoclonal antibody-based clearance medicines, will require rigorous clinical trials to determine optimal patient selection. Given the high cost of current ATTR-CM treatments, these trials are essential to identify
AI-powered diagnostic tests, even those offering significant cost reductions, face substantial delays in gaining regulatory approval and reimbursement. David Spetzler of a diagnostic company highlighted a breast cancer early recurrence test that could halve costs compared to existing options, yet is